RU2007147352A - SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS - Google Patents
SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS Download PDFInfo
- Publication number
- RU2007147352A RU2007147352A RU2007147352/04A RU2007147352A RU2007147352A RU 2007147352 A RU2007147352 A RU 2007147352A RU 2007147352/04 A RU2007147352/04 A RU 2007147352/04A RU 2007147352 A RU2007147352 A RU 2007147352A RU 2007147352 A RU2007147352 A RU 2007147352A
- Authority
- RU
- Russia
- Prior art keywords
- pyrido
- indole
- indoles
- azepino
- tetrahydro
- Prior art date
Links
- 0 Cc(cc1)cc2c1[n](CC(*)[Al])c1c2CN(*)CCC1 Chemical compound Cc(cc1)cc2c1[n](CC(*)[Al])c1c2CN(*)CCC1 0.000 description 2
- KPGWZRTZTASLIF-UHFFFAOYSA-N CN(CC1)Cc2c1[n](CCc1ccccc1)c1ccccc21 Chemical compound CN(CC1)Cc2c1[n](CCc1ccccc1)c1ccccc21 KPGWZRTZTASLIF-UHFFFAOYSA-N 0.000 description 1
- GGHZHHOSLOHEBP-UHFFFAOYSA-N Cc(cc1)cc2c1[n](CC(c1ccccc1)O)c1c2CN(C)CCC1 Chemical compound Cc(cc1)cc2c1[n](CC(c1ccccc1)O)c1c2CN(C)CCC1 GGHZHHOSLOHEBP-UHFFFAOYSA-N 0.000 description 1
- AVZFSLTZULXZCC-UHFFFAOYSA-N Cc1ccc(CC[n](c(CCN(C)C2)c2c2c3)c2ccc3F)cc1 Chemical compound Cc1ccc(CC[n](c(CCN(C)C2)c2c2c3)c2ccc3F)cc1 AVZFSLTZULXZCC-UHFFFAOYSA-N 0.000 description 1
- IOCNAYQXBFPPHY-UHFFFAOYSA-N Cc1ccc2[n](CCc(cc3)ccc3OC)c(CCCN(C)C3)c3c2c1 Chemical compound Cc1ccc2[n](CCc(cc3)ccc3OC)c(CCCN(C)C3)c3c2c1 IOCNAYQXBFPPHY-UHFFFAOYSA-N 0.000 description 1
Abstract
1. Лекарственные субстанции, обладающие нейротропной активностью по отношению к α-адреноцепторам, допаминовым D и серотониновым рецепторам ЦНС, общей формулы 1 в виде свободных оснований (или кислот) или в виде фармацевтически приемлемых солей и/или гидратов, для фармацевтических композиций и готовых лекарственных форм, предназначенных для лечения и/или предупреждения нейродегенеративных заболеваний и когнитивных расстройств. ! ! где R1 представляет собой заместитель аминогруппы, в том числе атом водорода, необязательно замещенный С1-С4алкил, ацил, алкокси, гетероциклил, замещенный сульфонил; ! R2 представляет собой заместитель циклической системы, в том числе атом водорода, атом галогена, необязательно замещенный С1-С4алкил, CF3, CN, алкокси, алкоксикарбонил, карбоксил, гетероциклил или замещенный сульфонил; ! Ar представляет собой, необязательно замещенный арил или необязательно замещенный гетероциклил; ! Alk представляет собой, необязательно замещенный С1-С3алкандиил, С2-С3алкендиил, С2-С4алкиндиил или группу SO2; ! n=1 или 2; ! сплошная линия с сопровождающей ее пунктирной линией () представляют одинарную или двойную связь. ! 2. Лекарственные субстанции по п.1, отличающиеся тем, что спектр их рецептор-специфичной агонстической и/или антагонистической активности включает активность по отношению к α1A, α1B, α1D, α2A адреноцепторам, допаминовым D1, D2L, D2S, D3 и D4.2 рецепторам и серотониновым 5-НТ2A, 5-НТ2B, 5-НТ2C, 5-НТ6 и 5-НТ7 рецепторам. ! 3. Лекарственные субстанции по п.1, отличающиеся тем, что спектр их рецептор-специфичной агонистической и/или антагонистической активности может включать и некоторые другие рецепторы, такие как гистаминовые H1, 1. Medicinal substances with neurotropic activity against α-adrenoceptors, dopamine D and serotonin receptors of the central nervous system, General formula 1 in the form of free bases (or acids) or in the form of pharmaceutically acceptable salts and / or hydrates, for pharmaceutical compositions and ready-made drugs forms intended for the treatment and / or prevention of neurodegenerative diseases and cognitive disorders. ! ! where R1 represents an amino group substituent, including a hydrogen atom, optionally substituted C1-C4 alkyl, acyl, alkoxy, heterocyclyl, substituted sulfonyl; ! R2 represents a cyclic system substituent, including a hydrogen atom, a halogen atom, optionally substituted C1-C4 alkyl, CF3, CN, alkoxy, alkoxycarbonyl, carboxyl, heterocyclyl or substituted sulfonyl; ! Ar is an optionally substituted aryl or optionally substituted heterocyclyl; ! Alk is optionally substituted C1-C3 alkanediyl, C2-C3 alkenediyl, C2-C4 alkindiyl or an SO2 group; ! n is 1 or 2; ! the solid line with the accompanying dashed line () represent a single or double bond. ! 2. Drug substances according to claim 1, characterized in that the spectrum of their receptor-specific agonistic and / or antagonistic activity includes activity with respect to α1A, α1B, α1D, α2A adrenoceptors, dopamine D1, D2L, D2S, D3 and D4.2 receptors and serotonin 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6 and 5-HT7 receptors. ! 3. The drug substance according to claim 1, characterized in that the spectrum of their receptor-specific agonistic and / or antagonistic activity may include some other receptors, such as histamine H1,
Claims (23)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147352/04A RU2007147352A (en) | 2007-12-21 | 2007-12-21 | SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
US12/810,013 US20110039825A1 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
PCT/RU2008/000780 WO2009082268A2 (en) | 2007-12-21 | 2008-12-19 | LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
JP2010539344A JP2011507835A (en) | 2007-12-21 | 2008-12-19 | Alpha-adrenergic receptor, dopamine, histamine, imidazoline and serotonin receptor ligands and uses thereof |
EP08864305A EP2236511A4 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147352/04A RU2007147352A (en) | 2007-12-21 | 2007-12-21 | SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008150397/04A Substitution RU2407744C2 (en) | 2008-12-19 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007147352A true RU2007147352A (en) | 2009-06-27 |
Family
ID=41026629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007147352/04A RU2007147352A (en) | 2007-12-21 | 2007-12-21 | SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2007147352A (en) |
-
2007
- 2007-12-21 RU RU2007147352/04A patent/RU2007147352A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015240521B2 (en) | Organic compounds | |
RU2661156C2 (en) | Substituted naphthyridine and quinoline compounds as mao inhibitors | |
JP2010502722A5 (en) | ||
RU2009103307A (en) | IMIDAZO DERIVATIVES [1, 2-a] PYRIDINE-2-CARBOXAMIDES, THEIR PRODUCTION AND APPLICATION IN THERAPY | |
WO2009082268A2 (en) | LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF | |
RU2009103300A (en) | DERIVATIVES OF 2-BENZOYLIMIDAZOPYRIDINES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY | |
RU2006105782A (en) | Derivatives of 1-Sulfonylindole, their preparation and their use as ligands 5-NT-6 | |
MX2009010242A (en) | Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor. | |
CN113164490A (en) | Treatment of pruritis with P2X3 antagonists | |
JP2005508381A5 (en) | ||
RU2007147352A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS | |
RU2006105778A (en) | INDOL-4-ILE SULPHONAMIDE DERIVATIVES, THEIR PRODUCTION AND APPLICATION AS 5-NT-6 MODULATORS | |
RU2008102155A (en) | SUBSTITUTED 3-SULFONIL- [1,2,3] TRIAZOLO [1,5-a] PYRIMIDINS-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, MEDICINES | |
RU2007147368A (en) | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS | |
CA2490254A1 (en) | Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them | |
RU2008102154A (en) | SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULFONYL-PYRAZOLO [1,5-a] PYRIMIDINS-ANTAGONISTS OF SEROTONIN 5-NT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEOSEPHERESIS | |
WO2015157451A1 (en) | Methods for treating attention deficit hyperactivity disorder | |
JP2005525385A5 (en) | ||
JP2004529936A5 (en) | ||
RU2007147355A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR ITS PRODUCTION AND APPLICATION FOR TREATMENT OF MENTAL DISEASES | |
RU2407744C2 (en) | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof | |
RU2007147351A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, WAYS OF ITS PRODUCTION AND APPLICATION FOR TREATMENT OF DISORDERS CAUSED BY CHEMICAL SUBSTANCES AND DEPENDENCE ON CHEMICAL SUBSTANCES | |
RU2007147372A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] LIGANDA INDOLES OF DOPAMINE RECEPTORS AND THEIR APPLICATION | |
JP5898233B2 (en) | Substituted hydrogenated thieno-pyrrolo [3,2-C] pyridines, ligands, pharmaceutical compositions and methods for using the same | |
RU2007147375A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] ALPHA LIGANDA INDOLES ADRENCEPTORS AND THEIR APPLICATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090605 |